HAVCR2 and neoplasm: Therefore, we evaluated the relationship between the expression of immune inhibitory molecules (TIGIT, PDCD1LG2, PDCD1, LAG3, HAVCR2, CTLA4, and CD274) in the immune ignorant, immune inactive, and hot tumor subtypes.